08:00 , Jan 5, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myelogenous leukemia (AML); leukemia Neuroblastoma Ras viral oncogene (NRAS); lysophospholipase I (LYPLA1; APT-1) Cell culture studies...